Guangzhou Ambition (LBP) Pharmaceutical Technology Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Public

  • Employees
  • 768

Employees

  • Stock Symbol
  • 688393

Stock Symbol

  • Investments
  • 4

  • Share Price
  • $2.65
  • (As of Friday Closing)

Guangzhou Ambition (LBP) Pharmaceutical Technology General Information

Description

Guangzhou LBP Medicine Science & Technology Co Ltd is engaged in production and sales of in vitro diagnostic reagents and instruments. The company's products include Fluorescence in situ hybridization (FISH) series; Immunohistochemistry (IHC) series; Liquid - based cytology (LBP) series; PCR series; and medical laboratory.

Contact Information

Website
www.gzlbp.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Self-Made 7, Road number 11
  • Nanxiang Three, Luogang District
  • Guangzhou, Guangdong 510663
  • China
+86 020
Primary Industry
Diagnostic Equipment
Stock Exchange
SHG
Vertical(s)
Corporate Office
  • Self-Made 7, Road number 11
  • Nanxiang Three, Luogang District
  • Guangzhou, Guangdong 510663
  • China
+86 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Guangzhou Ambition (LBP) Pharmaceutical Technology Stock Performance

As of 13-Nov-2026, Guangzhou Ambition (LBP) Pharmaceutical Technology’s stock price is $2.65. Its current market cap is $248M with 93.6M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.65 $2.74 $2.32 - $5.59 $248M 93.6M 2.08M -$0.05

Guangzhou Ambition (LBP) Pharmaceutical Technology Financials Summary

As of 30-Sep-2026, Guangzhou Ambition (LBP) Pharmaceutical Technology has a trailing 12-month revenue of $51.7M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 270,292 277,203 205,206 310,437
Revenue 51,669 47,897 65,611 70,290
EBITDA (5,672) (2,338) 5,807 7,047
Net Income (5,071) (6,539) 2,967 5,662
Total Assets 184,346 184,002 186,673 197,490
Total Debt 340 444 1,430 4,005
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Guangzhou Ambition (LBP) Pharmaceutical Technology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Guangzhou Ambition (LBP) Pharmaceutical Technology‘s full profile, request access.

Request a free trial

Guangzhou Ambition (LBP) Pharmaceutical Technology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Guangzhou Ambition (LBP) Pharmaceutical Technology Investments (4)

Guangzhou Ambition (LBP) Pharmaceutical Technology’s most recent deal was a Corporate with Fangxin for . The deal was made on 01-Jun-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Fangxin 01-Jun-2023 Corporate Other Healthcare Technology Systems
ThunderBio 23-Sep-2022 Later Stage VC Diagnostic Equipment
Gaugene 01-Jul-2022 Later Stage VC Diagnostic Equipment
Targene Biotech 10-Jun-2022 Later Stage VC Diagnostic Equipment
To view Guangzhou Ambition (LBP) Pharmaceutical Technology’s complete investments history, request access »

Guangzhou Ambition (LBP) Pharmaceutical Technology ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Guangzhou Ambition (LBP) Pharmaceutical Technology’s complete esg history, request access »

Guangzhou Ambition (LBP) Pharmaceutical Technology FAQs

  • When was Guangzhou Ambition (LBP) Pharmaceutical Technology founded?

    Guangzhou Ambition (LBP) Pharmaceutical Technology was founded in 2005.

  • Where is Guangzhou Ambition (LBP) Pharmaceutical Technology headquartered?

    Guangzhou Ambition (LBP) Pharmaceutical Technology is headquartered in Guangzhou, China.

  • What is the size of Guangzhou Ambition (LBP) Pharmaceutical Technology?

    Guangzhou Ambition (LBP) Pharmaceutical Technology has 768 total employees.

  • What industry is Guangzhou Ambition (LBP) Pharmaceutical Technology in?

    Guangzhou Ambition (LBP) Pharmaceutical Technology’s primary industry is Diagnostic Equipment.

  • Is Guangzhou Ambition (LBP) Pharmaceutical Technology a private or public company?

    Guangzhou Ambition (LBP) Pharmaceutical Technology is a Public company.

  • What is Guangzhou Ambition (LBP) Pharmaceutical Technology’s stock symbol?

    The ticker symbol for Guangzhou Ambition (LBP) Pharmaceutical Technology is 688393.

  • What is the current stock price of Guangzhou Ambition (LBP) Pharmaceutical Technology?

    As of 13-Nov-2026 the stock price of Guangzhou Ambition (LBP) Pharmaceutical Technology is $2.65.

  • What is the current market cap of Guangzhou Ambition (LBP) Pharmaceutical Technology?

    The current market capitalization of Guangzhou Ambition (LBP) Pharmaceutical Technology is $248M.

  • What is Guangzhou Ambition (LBP) Pharmaceutical Technology’s current revenue?

    The trailing twelve month revenue for Guangzhou Ambition (LBP) Pharmaceutical Technology is $51.7M.

  • What is Guangzhou Ambition (LBP) Pharmaceutical Technology’s annual earnings per share (EPS)?

    Guangzhou Ambition (LBP) Pharmaceutical Technology’s EPS for 12 months was -$0.05.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process